CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Jounce Therapeutics Inc Company Snapshot
Jounce Therapeutics Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Jounce Therapeutics Inc with three other companies in this sector in the United States: Caladrius Biosciences Inc (2016 sales of $35.28 million of which 100% was PCT Segment), Portola Pharmaceuticals Inc ($35.50 million ), and Aratana Therapeutics Inc ($38.55 million ).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Jounce Therapeutics Inc
  Stock Performance Chart for Jounce Therapeutics Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 21.76
(Figures in U.S. Dollars)
1 Week 32.9%   13 Weeks 63.4%  
4 Weeks 47.2%   52 Weeks n/a  
 
Jounce Therapeutics Inc Key Data:
  Ticker: JNCE Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 37,197,000
(Year Ending Jan 2017).
Employees: 85
  Currency: U.S. Dollars Market Cap: 701,667,781
  Fiscal Yr Ends: December Shares Outstanding: 32,245,762
  Share Type: Common Closely Held Shares: 4,971,652
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.